Carisoprodol
NDC 51525-5901, carisoprodol, tablet, from Mylan Pharmaceuticals Inc..
- Product NDC
- 51525-5901
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA011792
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/51525-5901 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARISOPRODOL250 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51525-5901-1 | 51525590101 | 100 TABLET in 1 BOTTLE (51525-5901-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7c9184c0-7a2e-11df-8c8d-0002a5d5c51bNADAC price for package 51525590101
GET /v1/drugs/nadac/51525590101
Use it
Look up 51525-5901 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51525-5901 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51525-5901. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.